Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy-Reference-Cited by-同舟云学术

Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy

Published:2016 Issue:6 Volume:63 Page:589-596
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Yamamoto Chiho¹,Miyoshi Hideaki¹,Ono Kota²,Sugawara Hajime¹,Kameda Reina¹,Ichiyama Mei¹,Yamamoto Kohei¹,Nomoto Hiroshi¹,Nakamura Akinobu¹,Atsumi Tatsuya¹

Affiliation:

1. Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan

2. Clinical Research and Medical Innovation Center, Hokkaido University Hospital, Sapporo 060-8648, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/63/6/63_EJ15-0749/_pdf

Reference20 articles.

1. 1. Japan Diabetes Clinical Data Management Study Group (2015) [accessed Sep 2015] Available from: http://jddm.jp/index.html.

2. 2. Tanaka S, Horimai C, Katsukawa F (2003) Ethnic differences in abdominal visceral fat accumulation between Japanese, African-Americans, and Caucasians: a meta-analysis. Acta Diabetol 40 Suppl 1: S302-304.

3. 3. Kashiwagi A, Kazuta K, Yoshida S, Nagase I (2014) Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus. J Diabetes Investig 5: 382-391.

4. 4. Vasilakou D, Karagiannis T, Athanasiadou E, Mainou M, Liakos A, et al. (2013) Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 159: 262-274.

5. 5. Rahmoune H, Thompson PW, Ward JM, Smith CD, Hong G, et al. (2005) Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes 54: 3427-3434.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antihypertensive Effects of SGLT-2 Inhibitors and Progress in Research;Advances in Clinical Medicine;2024

2. Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved;Clinical Nutrition;2023-12

3. Efficacy and Safety of Switching from Sitagliptin to Ipragliflozin in Obese Japanese Patients with Type 2 Diabetes Mellitus: A Single-Arm Multicenter Interventional Study;Clinical Drug Investigation;2023-11-07

4. Sarcopenia as a Little-Recognized Comorbidity of Type II Diabetes Mellitus: A Review of the Diagnosis and Treatment;Nutrients;2023-09-26

5. Efficacy and Safety of the Use of SGLT2 Inhibitors in Patients on Incremental Hemodialysis: Maximizing Residual Renal Function, Is There a Role for SGLT2 Inhibitors?;Biomedicines;2023-07-06